Contrasting opioid use for pain management in microvascular head and neck reconstruction: an international study

Int J Oral Maxillofac Surg. 2022 Nov;51(11):1412-1419. doi: 10.1016/j.ijom.2022.04.016. Epub 2022 May 20.

Abstract

Opioids are often the mainstay of postoperative pain management, despite strong evidence of their ill effects and potential for long-term addiction. The goal of this study was to quantify opioid use and contrast pain management strategies of multiple international institutions performing fibula free flap reconstruction. A retrospective multicenter cohort study was designed, including five international centers. For inclusion, the patients had to have undergone a primary fibula free flap reconstruction of the mandible. A total of 185 patients were included. The median opioid use across all centers at 72 hours was 133 oral morphine equivalents. The highest utilization was in the USA (P < 0.001), which was approximately six times that of Italy, four times that of Argentina, and twice that of India, despite all centers performing a similar procedure. Based on this study there are clear differences in prescribing practices and ideologies among surgeons from different countries.

Keywords: Analgesia; Free tissue flaps; Head and neck cancer; Microsurgery; Opioids; Pain management; Reconstructive surgical procedures.

Publication types

  • Multicenter Study

MeSH terms

  • Analgesics, Opioid / therapeutic use
  • Cohort Studies
  • Free Tissue Flaps* / blood supply
  • Head and Neck Neoplasms*
  • Humans
  • Pain Management / methods
  • Plastic Surgery Procedures* / methods
  • Retrospective Studies

Substances

  • Analgesics, Opioid